オートゴーナルIL-2サイトカイン受容体複合体を用いて設計されたT細胞の選択的標的化
Jonathan T Sockolosky1,2, Eleonora Trotta3, Giulia Parisi4
1Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
まとめ
エンジニアリングされたインタールイキン-2 (IL-2) 変種は,選択的にエンジニアリングされたT細胞を標的とし,毒性が低下したがん治療における機能を強化します. このアプローチは,採用細胞免疫療法の有効性を改善する見込みを示しています.
科学分野:
- 免疫学
- バイオテクノロジー
- 腫瘍学
背景:
- インタールイウキン-2 (IL-2) は,免疫療法におけるT細胞機能に不可欠であるが,プレイオトロプ的作用により毒性を引き起こす.
- 現在のIL-2療法では,望ましい免疫細胞を選択的に標的化できず,治療効果を阻害し,副作用を増加させています.
研究 の 目的:
- エンジニアリングされたT細胞の選択的なターゲティングのために,正交 IL-2 サイトカイン受容体ペアを設計する.
- 臨床前モデルにおけるこれらの人工 IL-2 変異体の有効性と安全性を評価する.
主な方法:
- IL-2 サイトカイン受容体の正交対 (ortho-IL-2) の発達
- T細胞にオルトIL-2受容体β (オルトIL-2Rβ) を導入して選択的に結合させる.
- アドプティブ・セル・セラピーのマウスがんモデルにおける in vitro および in vivo 試験.
主要な成果:
- インビトロとインビボで,選択的に標的となる,設計されたオルト・IL-2のCD4+とCD8+T細胞.
- 対象外効果は限られ,全身性毒性は無視できる.
- 臨床前のネズミのがんモデルで有効な結果が得られ,採用細胞治療の結果が改善されました.
結論:
- エンジニアリングされたオーソ-IL-2ペアは,設計されたT細胞の精密な増強のための合成方法を提供します.
- このアプローチは,採用細胞免疫療法の安全性と有効性を高める可能性を秘めています.
- IL-2シグナリングの選択的ターゲティングは 次世代がん治療の有望な戦略です
関連する概念動画
Orthogonal Trajectories
72
Orthogonal trajectories describe the geometric relationship between two families of curves that intersect each other at right angles. One illustrative case involves a family of parabolas that open sideways along the x-axis. These curves share a common shape but differ by a scaling parameter, resulting in a set of curves that all pass through the origin and widen at different rates.Determining Orthogonal TrajectoriesTo identify the orthogonal trajectories for these parabolas, the first step...
72
Internal Receptors
74.7K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
Types of Receptors: Cell Surface Receptors
27.7K
Cell-surface receptors, also known as transmembrane receptors, are cell surface, membrane-anchored (integral) proteins that bind to external ligand molecules. This type of receptor spans the plasma membrane and performs signal transduction, converting an extracellular signal into an intracellular signal. Ligands that interact with cell-surface receptors do not have to enter the cell that they affect. Cell-surface receptors are also called cell-specific proteins or markers because they are...
27.7K
Protein Complexes with Interchangeable Parts
3.0K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
3.0K
What is Genetic Engineering?
80.4K
Overview
80.4K
T Cell Activation and Clonal Selection
16.3K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.3K


